Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma

Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma

Abstract There is a great unmet clinical need to identify patients with thin primary cutaneous melanomas (T1, Breslow thickness ≤ 1 mm) who have a high risk for tumour recurrence and death from melanoma. Kin of IRRE-like protein 1 (KIRREL/NEPH1) is expressed in podocytes and involved in glomerular f...

Full description

Bibliographic Details
Main Authors: Sebastian Lundgren, Helena Fagerström-Vahman, Cheng Zhang, Liv Ben-Dror, Adil Mardinoglu, Mathias Uhlen, Björn Nodin, Karin Jirström
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Biomarker Research
Subjects:
Melanoma
KIRREL
NEPH1
Prognosis
Online Access:http://link.springer.com/article/10.1186/s40364-018-0153-8

Internet

http://link.springer.com/article/10.1186/s40364-018-0153-8

Similar Items